Estimates of 'smoking-free' mortality 900
Introduction
This paper focuses on the determinants of divergence in trajectories of female mortality at ages 65 years and over between different Western countries. 2 This is an attempt to bridge the gap between the literature on divergences and convergences in mortality across what is conventionally defined as a 'developed world', and the literature on the impact of smoking on population health. The core argument of this paper is that a significant part of the observed divergence could be attributed to differences in severity and timing of a smoking epidemic among females in different countries.
A number of studies of divergences and convergences in mortality across the world have been published over the past decade or so (Meslé, Vallin, and Andreev 2002 , Meslé 2004 , McMichael et al. 2004 , Vallin and Meslé 2004 , Moser, Shkolnikov, and Leon 2005 , Meslé and Vallin 2006 , Rau et al. 2008 ). Divergence of sub-Saharan Africa from the rest of the world during the 1990s and divergence of Eastern and Central Europe from Western countries approximately since the mid-1960s are examples of better understood types of divergence. In the first case, the epidemic of HIV/AIDS caused a drop in life expectancy (McMichael et al. 2004 , Vallin and Meslé 2004 , Moser, Shkolnikov, and Leon 2005 . In the second case, a lack of ability to embrace innovation in medical science in relation to treatment and prevention of cardiovascular diseases resulted in stagnation or an increase in adult mortality (Meslé, Vallin, and Andreev 2002 , Meslé 2004 , Vallin and Meslé 2004 . Over the 1990s following the opening of their political and economic systems to Western influences, certain Central European countries (e.g. Poland, Czech Republic) started convergence in mortality towards Western Europe while in others (Russian Federation, Ukraine) the divergence continued being also exacerbated by economic and social crisis (Meslé 2004 , Vallin and Meslé 2004 , Stuckler, King, and McKee 2009 .
The divergences within the Western world are less well understood. In overviews of old-age mortality, Meslé and Vallin (2006) and Rau et al. (2008) demonstrated two contrasting patterns of mortality change among females between the 1980s and the end of the 20 th century: a pattern of a large decrease in mortality exhibited by France and Japan and a pattern of a smaller decrease, stability or a certain increase in mortality shown by Denmark, the United States, and the Netherlands. Meslé and Vallin (2006) relate to ages 65 years and over while Rau et al. (2008) focus on ages 80 years and over. Although the main purpose of both studies was descriptive, some attempts were made 2 Throughout this paper the terms 'Western countries' or 'Western world' are used to denote countries of Western, Northern and Southern Europe, United States of America, Canada, Australia, New Zealand and Japan. This definition excludes the former Soviet Union and countries of Eastern and Cenral Europe that remained within the Soviet zone of influence in the second half of the 20th century.
to identify potential explanatory factors. Two explanatory hypotheses suggested by Meslé and Vallin (2006) are: (1) an improvement in the quality of mortality data and (2) differences in the functioning of health systems and perceptions of death. Neither hypothesis is satisfactory for the explanation of the observed phenomenon of divergence in routes of old-age mortality change in females, by the authors' own admission. The authors identify the phenomenon of diverging trends in old-age female mortality as 'a possible third stage in a historical series of divergence-convergence stages' (Meslé and Vallin 2006: 125) . Rau et al. (2008) , relying on earlier research, mentioned the possible influence of early life factors as well as changes in medical services to elderly population within the context of the Netherlands and spread of smoking among females within the context of Denmark as potentially important for an explanation of increase or stagnation of old-age female mortality in these countries. Clearly, further work is needed to understand the reasons behind the divergence between mortality schedules of Western countries.
I propose that the divergence in female old-age mortality is, to a very significant extent, due to the differential impact of smoking related mortality on female populations of France and Japan versus Denmark, the United States and the Netherlands. I expand the comparisons to include other Western countries and demonstrate a broader picture of divergences in old-age female mortality. In all cases a very large part of divergence can be accounted for by diverging trends in smoking related mortality. I also demonstrate that the end to the diverging trends is on the horizon.
Three types of evidence can be brought in support of this case. 1) Survey based estimates of smoking prevalence. 2) Levels and trends of mortality from lung cancer. 3) Indirect estimates of 'smoking free' and smoking related mortality based on an approach developed by Peto et al. (1992 Peto et al. ( , 1994 .
The need for different types of evidence arises from the fact that each type relates to a certain aspect of the basic phenomenon (smoking related mortality) and each type has its own limitations. Survey based estimates reflect the prevalence of smoking in a population but they may be affected by temporal and cross national inconsistencies of definitions of a 'smoker' and 'smoking', a recall bias, non-response and possible misreporting. Additionally, the amount of tobacco consumed in a population at any given point in time depends not only on the prevalence of smoking but also on its intensity, i.e. the number of cigarettes consumed per person per day. Lung cancer rates are closely related to smoking (Ravenholt 1990 , National Cancer Institute 1997 , being the most direct accumulated expression of the habit, but they say nothing about the impact of smoking on other types of mortality. Indirect estimates of smoking related mortality across the entire mortality schedule have been developed by Peto et al. (1992 Peto et al. ( , 1994 but they are based on an assumption of the universality of relative risks of smokers' mortality-which introduces a degree of uncertainty into the results of estimation. Using more than one indicator is therefore essential for obtaining sound conclusions in relation to the phenomenon of smoking related mortality.
The argument linking diverging trends in old-age female mortality to smoking relies on an extensive body of work that has been generated in demographic science over approximately the last 30 years. Smoking was causally linked to lung cancer in the first half of the 20 th century, with about 90% of deaths from this disease being attributed to smoking (Ravenholt 1990 , National Cancer Institute 1997 . However, the impact of smoking on individual and population health spreads beyond lung cancer. Smoking adversely affects health from a wide variety of conditions: cardiovascular diseases, respiratory diseases, and different types of cancer other than lung cancer (Peto et al. 1992 , 1994 , Thun et al.1995 , Wen et al. 2004 , Doll et al. 2004 .
The impact of smoking on trends in mortality was pointed out by Retherford (1975) who attributed to smoking about ¾ of the rise in sex differential in mortality before the 1970s. Waldron (1986) found that 40%-60% of sex differentials in adult mortality in different Western populations during the 1960s and 1970s could be attributed to smoking. Lopez, Collishaw, and Piha (1994) proposed a model of smoking epidemic based on the behaviour of lung cancer rates in populations, a principal feature of which is a 20-30 year lag between the wide adoption of smoking by the population of a given country and a rise in smoking related mortality in this population. Peto et al. (1992 Peto et al. ( , 1994 developed an indirect method of quantification of smoking related mortality, which enabled thorough documentation of the 'burden' of smoking related mortality across nations and of temporal changes. According to Peto et al. (1992 Peto et al. ( , 1994 and Peto et al. (2006) , from the mid-1970s until the end of the 20 th century, around 30% of male deaths at ages 35-69 years and around 20% of deaths at ages 70 years and over in countries of the European Union could be attributed to smoking. For females in the European Union the proportion of total deaths attributable to smoking rose between the 1970s and the 1990s from 5% to 11% in age groups 35-69 years and from 2% to 6% in age groups 70 years and over. Peto et al. (1992 Peto et al. ( , 1994 and Peto et al. (2006) also convincingly demonstrated that the majority of smoking related deaths are deaths from cardiovascular diseases rather than lung cancer. Valkonen and Van Poppel (1997) , Pampel (2002 Pampel ( , 2005 , Bongaarts (2006) and Janssen, Kunst, and Mackenbach (2007) implemented the method developed by Peto et al. (1992 Peto et al. ( , 1994 to show the crucial role of smoking in the widening and narrowing of sex differentials in mortality and also the usefulness of controlling for smoking related mortality for better understanding of both past trends of decline in mortality and the likely scenarios of future progress in extending longevity. Preston and Wang (2006) arrived at similar conclusions on the basis of the analysis of cohort patterns of smoking using a different method of quantification of smoking related mortality.
Data and method
I employ data on life expectancy, deaths and population counts from the Human Mortality database (2008) and the World Health Organization (2006) database. I employ smoking prevalence data from Forey et al. (2002) . I do not make use of any unpublished material. I use ratios of death rates as a principal technique to illustrate differences in mortality between countries and points in time.
This paper compares trends and levels of smoking and old-age female mortality in France, Italy, Spain, Japan, the Netherlands, the United States of America, Denmark, and England and Wales. For each country, I present (1) survey based statistics on smoking prevalence (i.e. percent of persons defining themselves as smokers) and (2) trajectories of total, lung cancer and 'smoking free' mortality in 1951-1953, 1962-1964, 1973-1975, 1984-1986, and 1995-1997 3 . Although the main focus of this paper is on the developments in old-age female mortality between the 1970s and the 1990s, presentation of a longer time span (1950s-1990s) allows proper examination of the course of the smoking epidemic.
Indirect estimation of smoking related mortality has been developed by Peto et al. (1992 Peto et al. ( , 1994 and has been implemented a number of times in the literature. The core features of the procedure are (1) estimation of smoking prevalence on the basis of lung cancer rates 4 and (2) computation of the number of excess (smoking related) deaths using the estimated smoking prevalence and relative risks of smoking derived from the second wave of the American Cancer Society Cancer Prevention Studies. Smoking related deaths can be subsequently removed from mortality schedules to render 'smoking free' mortality (Peto et al. 1992 (Peto et al. , 1994 . Further details of the method can be 3 The exceptions are France where data for years 1952-1953 were used instead of 1951-1953 , and Denmark, the Netherlands and Japan where data for years 1992 -1993 , 1993 -1995 and 1992 -1994 , respectively, were used instead of 1995 . For brevity I will refer to years 1951 -1953 as 'the 1950s', years 1962 -1964 as 'the 1960s' and so forth. 4 The estimated 'smoking prevalence' figures are, in fact, estimates of smoking prevalence and intensity 20-30 years ago, simply because the lung cancer rate at time T is a function of prevalence and intensity of smoking at time T-25 years, approximately. Such estimates are presumably more precise than the smoking prevalence figures reported in surveys simply because they are not complicated by a recall bias, non-response, misreporting of a habit, and definitional differences.
found in Appendix as well as in Peto et al. (1992 Peto et al. ( , 1994 , Valkonen and Van Poppel (1997) , Brønnum-Hansen and Juel (2000) , and Pampel (2005) .
All countries participating in comparisons possess well developed systems of vital registration and population accounts. The use of mortality records of these countries is widely accepted, and in most cases there are no concerns about the quality of mortality data. One issue, however, stands out as somewhat problematic. Certain countries possess significant proportion of deaths attributed to ill-defined causes. This problem is especially severe at earlier points in time. During the 1950s the proportion of all deaths at ages 65 years and over attributed to ill-defined causes (codes A136 and A137 of the International Classification of Diseases 7, List A, condensed) is 22% in France and Japan, 14%-18% in Italy and Spain, 6% in the Netherlands and only 1.0%-2.5% in the United States, Denmark, England and Wales. During the 1990s, the proportion of deaths coded as ill-defined (code B46 of the International Classification of Diseases 9, Basic Tabulation List) is relatively low in all countries: in the 1990s it is 4.5%-6.0% in France and Japan and it is below 4% in nearly all other countries examined in this paper. Since the estimation of smoking related mortality relies on cause-specific information on deaths, differential scope of ill-defined mortality across countries may adversely affect comparability of estimates.
High proportion of ill-defined causes both in historical and contemporary mortality data has been noted in previous research (Preston 1976 , United Nations 1988 , Gage 1993 , 1994 , Meslé and Vallin 1996 , Meslé 1999 and it has been maintained that illdefined deaths are mainly deaths from the endogenous causes, mostly cardiovascular diseases and cancer (Preston 1976 , United Nations 1988 , Gage 1993 , 1994 . As a way to control for the differential scope of ill-defined deaths in different countries Meslé (1999) proposed to re-distribute ill-defined deaths proportionally between specific categories for the purpose of analysis of mortality trends. In this paper, I follow the method proposed by Meslé (1999) 5 . Specifically, first I calculate proportions of various causes of death participating in estimation of smoking related mortality of the total number of deaths with known causes. I then apply these proportions to ill-defined deaths to obtain the 'extra' deaths for each cause of death taking part in estimation. Finally, I add the 'extra' deaths to the 'original' deaths with known causes. I perform the estimation of smoking related mortality on the basis of the corrected counts of deaths by cause.
Diverging trends in female life expectancy at age 65
The developed world has experienced a divergence of mortality schedules of females aged 65 years and over. Figure 1 shows trends in female life expectancy at age 65 in France and the United States, which were earlier presented by Meslé and Vallin (2006) and Rau et al. (2008) , but also in other countries: Denmark, England and Wales, Italy, and Spain. As trends in Japan and the Netherlands are rather similar to those in France and the United States, respectively, I do not present these trends to avoid 'cluttering' the diagram. Roughly up to the mid-1970s all presented countries display similar trends of increase in life expectancy. In Italy and Spain, as in France, the increase is continuous also between the 1970s and the beginning of the 21 st century. However, Denmark, The outcome of the diverging trends is a much greater variation in female life expectancy at age 65 in 2005 than in 1950. The 'French' pattern of a more or less continuous rise in life expectancy has been also seen, apart from Japan and other Mediterranean countries of Europe, in Austria, Australia, Belgium, Finland, and Switzerland. On the other hand, the 'American' pattern of a slower rise or certain stagnation has been followed, apart from Denmark, the Netherlands, England and Wales, also by Canada, New Zealand, Norway, and Sweden. The exact timing and the nature of divergence from the 'French' pattern varied significantly within this second group.
The link between smoking and diverging trends in old-age mortality among females: evidence examined

Survey based estimates of smoking prevalence
The effects of smoking in teenage years and young adulthood are felt chiefly after the age of 45 years. It is known that the effects of smoking on health and mortality are lagged by about 20-30 years, both on an individual and population level (Lopez, Collishaw, and Piha 1994) . Therefore, the impact of smoking related mortality on oldage mortality in the end the 20 th century is a function of the exposure of middle-aged adults to smoking approximately during the 1970s. Figure 2 sets out the comparisons of trends in prevalence of smoking among middle-aged females in a few countries where data on smoking prevalence could be obtained for three points in time in a comparable format.
It is well known that the mass adoption of smoking by females started later in Southern Europe and Japan than in Northern Europe and the United States (Pampel 2003) . Figure 2 shows that at all times the prevalence of smoking among middle-aged females is lower in France and Italy than in the United States, England and Wales, and Denmark. Specifically, during the 1950s and 1970s the prevalence of smoking in France (11%-17%) is about half of what is at the same time observed in the United States (26%-34%), and in Italy during the 1970s (14%) it is 2.5 times lower than in the United States. The gap between France and Italy on one hand and the United States on the other hand narrows during the 1990s. However, it is important to remember that the figures that are relevant for understanding mortality at ages 65 years and over during the last quarter of the 20 th century are those relating to prevalence of smoking among females aged 45-64 years specifically in the mid-1970s. The results of the narrowing observed in the 1990s will not have a perceptible impact on trends in old-age mortality until 20-30 years later. (2) A certain degree of cross national variation in definition of a smoker exists. Forey et al. (2002) should be consulted for greater details. Source: Forey et al. (2002) More detailed comparisons of smoking prevalence figures for the mid-1970s are set out in Table 1 . Age groups to which particular attention should be paid are shaded. Note: Age groups are presented as they appear in the source publication. Source: Forey et al. (2002) Examination of the data presented in Table 1 provides the following insights. First, during the 1970s the prevalence of smoking among middle-aged females in Japan is approximately at the same level as in France and Italy (about 17%) while in Spain it is at a lower level (5%). In the Netherlands the prevalence of smoking among the middleaged females is roughly at a level observed in the United States, England and Wales, and Denmark. Second, in younger age groups (ages 25-40 years) the prevalence of smoking among females in France and Italy is more similar to the United States, England and Wales, Denmark, and the Netherlands (being in the range of range of 30%-50%) while in Japan and Spain it is still considerably lower (around 15%).
The most important conclusion that can be drawn on the basis of the data on the prevalence of smoking is the conclusion regarding the existence of two 'clusters' of countries: the United States, England and Wales, Denmark, and the Netherlands on one hand and France, Italy, Spain, and Japan on the other hand. In the first 'cluster' the scope of smoking among females is more significant; specifically, already during the 1970s around one third of middle-aged females in these countries smoked. In the second 'cluster' the scope of smoking among middle-aged females remained much lower (in the range of 5%-17% in the 1970s). We can therefore anticipate that the subsequent impact of smoking related mortality would be higher in Northern Europe and the United States than in Southern Europe and Japan 6 . Importantly, two 'clusters' correspond well to the 'American' and 'French' patterns of trends in female life expectancy at age 65, identified in Figure 1. 
Mortality from lung cancer
Death rates from lung cancer rates at a given point in time reflect the smoking history of 20-30 years before. About 90% of deaths from lung cancer are related to smoking. Trends in mortality from lung cancer were used in the past as a proxy for description of all-cause smoking related mortality by Lopez, Collishaw, and Piha (1994) . There are indications that trends in lung cancer are a more appropriate measure for the assessment of the impact of smoking than the survey based smoking prevalence figures.
In Figure 3 , I show the trends and levels of old-age female mortality from lung cancer in different countries between the 1950s and the 1990s 7 .
As Figure 3 demonstrates, the differences between countries in levels of mortality from lung cancer are noticeable already in the 1950s with England and Wales, the United States, and Denmark presenting higher levels than Southern Europe, Japan, and the Netherlands. However, the general level of lung cancer mortality is still quite low during the 1950s. The rise in old-age female mortality from lung cancer starts in the 1950s and occurs in all countries under examination. The divergence in routes of mortality from lung cancer is especially pronounced since the 1970s: the rise is much steeper in the United States, England and Wales, and Denmark (countries that by the 1980s form a clear visual 'cluster' of high mortality from lung cancer) than in Southern Europe and Japan (countries forming a 'cluster' of low mortality from lung cancer). The Netherlands appears to occupy an intermediate position between the two 'clusters'. 6 For brevity I will use a term 'Northern Europe' while referring to Denmark, England and Wales, and the Netherlands and a term 'Southern Europe' in relation to France, Italy and Spain. 7 Standardization of the death rates throughout this paper is performed using the weights obtained from the total European population (including Western, Eastern, Northern and Southern Europe) as an average of years 1955 , 1975 , and 1995 (United Nations 2007 . Remarkably, approximately since the 1970s the behaviour of old-age female lung cancer mortality shown in Figure 3 , and in particular the appearance of the clearly differential trends resulting in 'clusters', resembles the behaviour of female life expectancy at age 65 shown in Figure 1 , where similar differentiation in trends and clustering (i.e. 'French' and 'American' patterns) were identified. The Netherlands constitutes a single exception: this country is identified as a part of the 'American' pattern in relation to the route of female life expectancy at age 65 but it is clearly not part of a 'cluster' containing the United States, England and Wales, and Denmark in relation to the trend in female old-age mortality from lung cancer.
I now focus more closely on the developments between the 1970s and 1990s. In Figure 4 , I present ratios of age-specific female death rates from lung cancer in different countries to those observed in France in the mid-1990s. Only ratios for ages 65-84 years are presented as the rates in an open age group might be affected by the differences in age composition. Also, lung cancer rates are not very reliable at ages 75 years and over (Peto et al. 1992) , and all comparisons in this age group should be made with care. It is quite clear from Figure 4 , that in the 1990s lung cancer mortality of French females was lower than in most countries across all age groups within the span of ages 65-84 years. Lung cancer mortality of Spanish and Italian females was also relatively low. Lung cancer mortality of Japanese females at ages 65-74 years was similar to that of Italian females. In England and Wales, Denmark, and the United States lung cancer mortality rates were 3-5 times higher than in France, and in the Netherlands they were approximately 1.5-2.5 times higher (except in the age group of 80-84 years). Japanese female lung cancer death rates at ages 75 years and over appear somewhat problematic: the level of lung cancer mortality is higher than what can be expected from the prevalence of smoking figures and in the last presented age group (80-84 years) it approximates the level observed in Denmark, a country with a much greater prevalence of smoking. In view of the point made by Peto et al. (1992) about possible reliability issues in relation to death rates from lung cancer at the most advanced ages there is a reason to suspect that Japanese mortality from lung cancer at these ages is somewhat overestimated. Figure 4 also allows better understanding of certain features of old-age female mortality from lung cancer in the Netherlands which escaped attention in presentation of age-standardized death rates from lung cancer in Figure 3 : in the 1990s ages 64-74 years in the Netherlands have higher mortality from lung cancer than Southern Europe (but not as high as in the United States, England and Wales, and Denmark) while at ages 75-84 years mortality from lung cancer is approximately at the same level as in Southern Europe. This is an illustration of a relatively late timing of smoking epidemic in the Netherlands in comparison to the rest of Northern Europe and the United States. As a result, only the younger ages in the age span of 65-84 years in the Netherlands exhibit elevated lung cancer mortality while there are no signs of the epidemic at the older ages. This interpretation is compatible with the conclusions regarding national differences in the timing of smoking epidemic presented by Pampel (2003: 57-58) . Figure 5 presents the ratios of female lung cancer death rates in the same set of countries to French female lung cancer death rates in the mid-1970s. At this point in time, variation in lung cancer mortality is much smaller than in the 1990s: nearly all ratios are below 3. Still, countries of Southern Europe and Japan form a group of low mortality from lung cancer among females (Spain is almost indistinguishable from France) while England and Wales, Denmark, and the United States constitute a group of high mortality from lung cancer. Curiously, Dutch mortality from lung cancer is very similar to French in the 1970s and it is quite different in the 1990s, i.e. the Netherlands moves from the 'pole' of low lung cancer mortality towards the 'pole' of high lung cancer mortality among females aged 65 years and over. The increase in ratios of death rates from lung cancer between the 1970s and the 1990s in different countries relative to French mortality provides an illustration of diverging schedules of the type of mortality with the strongest link to smoking.
To be sure, no country remained static in relation to mortality from lung cancer. To further highlight this point Figure 6 presents ratios of female death rates from lung cancer in the 1990s to those observed in the 1970s for each country.
In Southern Europe and Japan, countries with initially low smoking related mortality, the increase in most age groups was 2 fold or below this figure. It still remained less significant than in Northern Europe, and, especially, in the United States where a 2-4 fold increase was observed. 
Estimates of 'smoking-free' mortality
This section presents the final and most convincing type of evidence linking the observed divergence in female old-age mortality to the impact of smoking related mortality. An indirect estimation of smoking related mortality using a method developed by Peto et al. (1992 Peto et al. ( , 1994 showed that in the 1990s the volume of smoking related mortality among females aged 65 years and over in France, Italy, Spain and Japan was modest relative to Denmark, the Netherlands and the United States. Only 2% of female deaths at ages 65 years and over in France, 5% in Italy and 6% in Japan were related to smoking. In Spain almost no deaths among females in these age groups were smoking related. In Denmark, England and Wales, the Netherlands, and the United States the proportions of smoking related deaths were 15%, 16%, 8% and 20%, respectively. Figure 7 shows trends in old-age mortality for females in different countries (Panel A) and also trends in old-age female mortality after reduction of smoking related deaths (Panel B) using a method developed by Peto et al. (1992 Peto et al. ( ,1994 . Reduction of smoking related deaths makes little impact on old-age female mortality before the 1980s. Since the 1980s, however, and especially during the 1990s, divergence in female old-age mortality seen in Panel A is significantly reduced as a result of reduction of smoking related deaths (Panel B). In fact, variation in 'smoking free' mortality is smaller in the 1990s than it is in the 1950s (Panel B).
One feature of the method of quantification of smoking related mortality developed by Peto et al. (1992 Peto et al. ( , 1994 ) is worth repeating while interpreting these results: the estimation procedure is a conservative one. In the process of estimation Peto et al. (1992 Peto et al. ( , 1994 suggested to halve the excess risks for smoking, based on American Cancer Society Cancer Prevention Studies, for all causes of death but lung cancer to adjust for possible confounding effects. Therefore, all estimates of smoking related mortality obtained with the help of this procedure are almost certainly underestimates. Presentation in Figure 7 is based on the conservative version of estimation originally proposed by Peto et al. (1992 Peto et al. ( , 1994 . I also propose a modification to the original estimation procedure developed by Peto et al. (1992 Peto et al. ( , 1994 . Figure 8 presents two types of estimates of smoking related mortality. The first estimate relies on the original procedure developed by Peto et al. (1992 Peto et al. ( , 1994 where the excess risks are halved. The second estimate does not implement halving of the excess risks. These estimates represent the minimal and the maximal estimates of smoking related mortality, respectively. Consequently, I obtain two estimates of 'smoking free' mortality: the first is almost certainly an overestimate and the second is an underestimate. The 'true' figure is most likely to be found somewhere in between these two estimates. Figure 8 shows ratios of death rates among females at ages 65 years and over in selected countries to those observed among French females during the 1990s, before and after smoking related mortality is removed. In all countries apart from Spain, ratios of female death rates to those observed among females in France are higher for total mortality than for 'smoking free' mortality. A reduction of smoking related mortality does not eliminate the phenomenon of lower old-age mortality of French females but it attenuates it significantly. For example, the ratio of American death rate to French death rate is 1.32 before smoking related mortality is removed and in a range of 0.96-1.06 after. The corresponding figures for England and Wales are 1.42 and 1.10-1.20 and for Denmark they are 1.73 and 1.25-1.34. In the Netherlands a reduction in ratios is also observed following the removal of smoking related mortality; however, it is less significant than in other countries. The ratios of Dutch to French death rate are 1.33 and 1.24-1.27 before and after the removal of smoking related mortality, respectively. Figure 9 (Panels A, B and C) presents ratios of death rates observed in the 1990s to those in the 1970s, for total and 'smoking free' mortality. When the change in total mortality is considered (Panel A), Southern European countries and Japan again form a 'cluster' of countries exhibiting a large change: ratios of death rates in the 1990s to those observed in the 1970s in these countries are around or below 0.6 (age groups 65-84 years). Northern European countries and the United States stand out as a 'cluster' with relatively small improvement: as a rule their ratios are above 0.7 and in many age groups they are in a range of 0.8-0.9. In Denmark, an increase in mortality in age group 65-69 years is observed between the two periods. The removal of smoking related mortality makes the pace of improvement in oldage female mortality considerably more similar across countries participating in a comparison (Panels B and C). The change in mutual positioning of different countries is noticeable when the original method developed by Peto et al. (1992 Peto et al. ( , 1994 ) is implemented and it is especially significant when the modified version of it is applied. After smoking related mortality is removed the ratios of death rates in the 1990s to those observed in the 1970s are all in a range of 0.6-0.7 in England and Wales and the United States (Panels B and C). In Southern European countries and Japan the ratios remain within the range of 0.5-0.6. The picture of 'clustering' clearly visible in Panel A disappears in Panels B and C. A large gap in the pace of improvement still remains between Denmark and the Netherlands, on one hand, and all other countries (but especially Southern European countries and Japan), on the other hand.
Re-thinking the stages of the health transition
This paper has shown that old-age female life expectancy continued to rise in a more or less undisturbed manner through the second half of the 20 th century in countries mildly affected by smoking epidemic among females (France, Italy, Spain, and Japan). Oldage female mortality stagnated (Denmark) or a slowdown in pace of improvement has been observed (the United States, the Netherlands, England and Wales) in countries significantly affected by smoking epidemic. This resulted in divergence of their mortality schedules from those of France, Italy, Spain, and Japan. Waldron (1985) identified smoking as the most important single factor behind sex differentials in mortality. This analysis suggests that smoking might also qualify for the most important single factor in the diverging trends in (and growing variation of) female old-age mortality during the last quarter of the 20 th century. This argument rests on a simple inspection of appropriately lagged smoking prevalence figures, comparisons of trends and levels of mortality from lung cancer and results of quantification of smoking related and 'smoking-free' mortality using the method developed by Peto et al. (1992 Peto et al. ( , 1994 .
Surveys of smoking habits indicated that during the 1970s smoking was significantly less prevalent among females aged 45-64 years in Southern Europe and Japan than in Northern Europe and the United States. Consequently, mortality of females aged 65 years and over in these groups of countries in the 1990s would be differently affected by smoking. Females aged 65 years and over in Southern Europe were less affected by mortality from lung cancer than females in Northern Europe and the United States. This was true both during the 1970s and the 1990s. Although for French and Italian (but not Spanish) females' lung cancer mortality increased, it did so less than in Northern Europe countries and the United States. Finally, the removal of smoking using the method developed by Peto et al. (1992 Peto et al. ( , 1994 revealed that 'smoking free' death rates in Southern Europe and Japan, on one hand, and Northern Europe and the United States, on the other hand, were much more similar than those observed before smoking related mortality was removed. The Netherlands constitutes an exception: the phenomenon of relatively high and stagnating old-age female mortality in the Netherlands in the 1980s and 1990s deserves special attention: in contrast to the United States, England and Wales, and Denmark it does not appear to be largely due to smoking related mortality.
Since the 1960s, mortality schedules of Western countries reflected what Vallin and Meslé (2004) labelled as 'cardiovascular revolution': a dramatic reduction in cardiovascular and total mortality following the introduction of innovative medical technologies and advances in preventive medicine in relation to cardiovascular diseases. Does the divergence in old-age female mortality since the 1980s mark the beginning of a new stage of health transition, as suggested by Meslé and Vallin (2006) ? There is no straightforward answer to this question. The stage of cardiovascular revolution is not over: technologies of the treatment of cardiovascular diseases are constantly developing in Western countries and they are being disseminated in Eastern European countries. Mass adoption of smoking by females in countries such as England and Wales and the United States occurred before the beginning of the cardiovascular revolution but its effects on health and survival remained hidden until the 1980s, when the first female cohorts significantly affected by smoking entered old age. Therefore, smoking can be seen as a force operating in parallel to the cardiovascular revolution and offsetting its gains. Future work should further address the issue of interplay of smoking and the cardiovascular revolution in determining the survival outcomes across countries.
There is one more point of significance in relation to the impact of smoking on female old-age mortality. Although with delay, smoking became widespread among young French and Italian females during the 1970s, as Table 1 testifies: in age group 25-35 years, prevalence of smoking among French females was no different from American females. Smoking also affected young females in Spain and Japan but to a lesser extent. These cohorts have been reaching old age during the first decade of the 21 st century and will dominate the second and the third decades. One can reasonably expect a slowdown in survival gains of females aged 65 years and over in these countries in the first quarter of the 21 st century. This, in turn, should cause a slowdown or a complete stop in the process of divergence in old-age female mortality seen up until 2000.
The first signs of this are already on the horizon. A careful examination of the process of change in life expectancy at age 65 (Figure 1 ) in France and Spain, for example, reveals a certain degree of slowing down at the most recent times. At the same time, in the United States, Denmark, and England and Wales improvement in life expectancy at old ages has been accelerating. Table 2 gives a better view of these processes presenting ratios of life expectancy at age 65 in 1995 to those observed in 1985 and in 2005 to those in 1995. As is shown in Table 2 , the greatest improvement between the mid-1980s and mid1990s occurred in France, Italy, Spain, and Japan while between the mid-1990s and 2005 the greatest improvement was registered in Denmark, England, Wales, and Japan. Also, the pace of improvement slowed down for France, Italy, and Spain while it increased in Denmark, England and Wales, and the United States. The acceleration in improvement in female life expectancy at age 65 in selected countries of Northern Europe and the United States could have something to do with reductions in prevalence and intensity of smoking in the later cohorts. Both types of reductions are possibly related to anti-smoking public health campaigns that took place since the 1970s in countries that were forerunners of smoking epidemic (Doll et al. 2004, Preston and Wang 2006) . In the United Kingdom and the United States, the decline in the proportion of smokers and in number of cigarettes smoked per person per day for females aged 65 years and over was registered in the first decade of the 21 st century (PN Lee Statistics & Computing Ltd 2007, Preston and Wang 2006) .
Clearly, however, smoking is not the only factor affecting the differences between countries in relation to old-age female mortality. Even after smoking related mortality is removed, differences in levels and trends of mortality persist, most remarkable are the differences between the Netherlands and Denmark with relatively high 'smoking free' mortality and slow pace of reduction during the last quarter of the 20 th century, on one hand, and France and Japan, where 'smoking free' mortality was low and the pace of reduction was faster (Figures 8 and 9 ). Meslé and Vallin (2006) suggested that attitudes to death and health at old-age and the functioning of health care systems might explain those differences. However, there are other factors, similar to smoking in magnitude of their impact on population health, that might be relevant for explanation. McGinnis and Foege (1993) and Mokdad et al. (2004) quantified mortality related to poor diet and physical inactivity in the United States to show that these represented the second largest health hazard in the last decade of the 20 th century (after smoking), causing 14%-17% of all avoidable deaths. Nutritional habits and exercise is therefore another important factor that interferes with and slows down the progress made as a result of innovation in medical sphere. Simple inspection of health indicators relating to diet and body mass reveals significant differences between the countries in this comparison. The proportion of females overweight and obese (i.e. those with body mass index above 25kg/m 2 ) in 2000 is in the range of 21%-33% in France, Italy, and Japan, and 34%-62% in Denmark, the Netherlands, the United Kingdom, and the United States (Organization for Economic Co-operation and Development 2008). Diet in Italy and Spain is richer in fruit, vegetables, and vegetable oil and lower in animal fat than it is in Northern Europe and Anglophone countries. The Japanese diet is especially low in animal fat and also in meat products in general (Food and Agriculture Organization of the United Nations 2006). France is more similar to Northern Europe and Anglophone countries in relation to dietetic components-the phenomenon has been commented on previously within the context of the so-called 'French mortality paradox'. Low mortality in France is not well understood and relatively high consumption of red wine as well as a time lag explanation (i.e. lower consumption of animal fat in France in comparison to Northern European countries in the past rather than at present) have been advanced to explain it (Law and Wald 1999) .
It is beyond the scope of this paper to quantify the impact of all lifestyle related factors, apart from smoking, on mortality schedules of females in countries under examination. However, it is important to point out their existence and the need to consider these factors in their interaction with smoking and the advancement in medical science in influencing old-age female mortality across the developed world.
The method of quantification of smoking related mortality
All calculations and elements of notation detailed in this Appendix are age-and sexspecific, unless otherwise stated.
Calculations proceed through the following four stages.
1) Computation of the excess deaths from lung cancer for each country (country X) through the application of the American non-smokers' age and sex-specific lung cancer death rates (from the second wave of the American Cancer Society Cancer Prevention Study, ACS CPS-II) to population figures of country X. The difference between the actual number of deaths from lung cancer in country X and the 'would be' number (if country X experienced lung cancer death rates of non-smokers) represents the excess mortality from lung cancer in this country.
2) Computation of the proportions of smokers and non-smokers in country X, assuming that the observed death rates from lung cancer in country X are a weighted sum of rates of smokers and non-smokers. This procedure relies on an assumption that American non-smokers' lung cancer rates and relative risks in relation to lung cancer (from ACS CPS-II) are universal.
3) Computation of the proportion of smoking related deaths in country X (called also an etiologic fraction) for causes other than lung cancer. Etiologic fraction (EF) is a function of the proportion of smokers (P), calculated at a previous step, and of the cause-specific relative risks (RR) of smokers to non-smokers obtained from ACS CPS-II: *( 1 1 *(
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However, Peto et al. (1992 Peto et al. ( , 1994 suggest halving of the relative risks to generate conservative estimates. *( 1 2 *(
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